98 studies found for:    aspirin | United States, New York | Studies with Male Participents
Show Display Options
Rank Status Study
21 Active, not recruiting Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Interventions: Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral Capsule
22 Terminated Clopidogrel and Aspirin for the Treatment of Polycythemia Vera
Condition: Polycythemia Vera
Interventions: Drug: Clopidogrel (Plavix);   Drug: Placebo;   Drug: Aspirin
23 Recruiting LIPS-A: Lung Injury Prevention Study With Aspirin
Condition: Acute Respiratory Distress Syndrome
Interventions: Drug: Aspirin;   Drug: Lactose powder
24 Completed Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects
Condition: Gastroduodenal Ulceration
Interventions: Drug: PL2200;   Drug: Aspirin tablets
25 Completed
Has Results
Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
Condition: Dyslipidemia
Interventions: Drug: niacin extended-release (NER);   Drug: aspirin (ASA);   Drug: aspirin placebo (ASA Pbo)
26 Completed Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
Condition: Chronic Kidney Disease
Intervention:
27 Completed Patent Foramen Ovale in Cryptogenic Stroke Study
Conditions: Ischemic Stroke;   Patent Foramen Ovale
Interventions: Drug: Warfarin;   Drug: Aspirin
28 Completed Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers
Condition: Gastroduodenal Ulcer
Interventions: Drug: Naproxen;   Drug: Aspirin;   Drug: Celecoxib;   Drug: Clopidogrel;   Drug: Placebo
29 Active, not recruiting The Dual Antiplatelet Therapy Study (DAPT Study)
Condition: Coronary Artery Disease
Interventions: Drug: Placebo & Aspirin;   Drug: Clopidogrel & Aspirin, Prasugrel & Aspirin
30 Terminated A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Simvastatin;   Drug: Aspirin;   Drug: Placebo
31 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
32 Recruiting Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
Conditions: Type-2 Diabetes Mellitus;   Coronary Artery Disease
Interventions: Drug: Ticagrelor + Aspirin;   Drug: Clopidogrel + Aspirin
33 Recruiting Edoxaban in Peripheral Arterial Disease
Condition: Peripheral Arterial Disease
Interventions: Drug: edoxaban;   Drug: Clopidogrel;   Drug: Aspirin
34 Completed Antithrombotic Effects of Ticagrelor Versus Clopidogrel
Condition: Acute Coronary Syndrome
Interventions: Drug: Ticagrelor + ASA + Bivalirudin;   Drug: Clopidogrel + ASA + Bivalirudin
35 Completed A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Aspirin;   Drug: clopidogrel
36 Completed Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: nitric oxide-releasing acetylsalicylic acid derivative;   Other: laboratory biomarker analysis;   Procedure: biopsy
37 Active, not recruiting PROMUS Element Plus US Post-Approval Study
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus Coronary Stent System;   Drug: Aspirin;   Drug: P2Y12 antagonist
38 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
39 Completed Warfarin and Antiplatelet Therapy in Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Warfarin titrated to an INR of 2.5-3.0;   Drug: Aspirin;   Drug: Clopidogrel 75
40 Completed Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
Condition: Peptic Ulcers
Interventions: Drug: Celecoxib;   Drug: Naproxen;   Drug: ASA

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years